<?xml version="1.0" encoding="UTF-8"?>
<eudamedExport entity="devices">
  <row>
    <udiDi>112065738638</udiDi>
    <basicUdiDi>PP07498KPRO16</basicUdiDi>
    <tradeName>KIJIMEA® REIZDARM PRO</tradeName>
    <deviceName>KIJIMEA® REIZDARM PRO</deviceName>
    <manufacturerName>Synformulas GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000016381</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>G0401</emdnCode>
    <emdnDescription>ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>N/A</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-07-22T12:29:03.377Z</lastUpdated>
  </row>
  <row>
    <udiDi>111129962848</udiDi>
    <basicUdiDi>PP23833V9017.IIB.A68</basicUdiDi>
    <tradeName>Fructaid</tradeName>
    <deviceName>Fructaid</deviceName>
    <manufacturerName>Vitacare GmbH &amp; Co. KG</manufacturerName>
    <manufacturerSrn>DE-MF-000022472</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>G0401</emdnCode>
    <emdnDescription>ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>11299628</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-07-22T12:29:02.556Z</lastUpdated>
  </row>
  <row>
    <udiDi>111129963414</udiDi>
    <basicUdiDi>PP23833V9017.IIB.A68</basicUdiDi>
    <tradeName>Fructaid</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Vitacare GmbH &amp; Co. KG</manufacturerName>
    <manufacturerSrn>DE-MF-000022472</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>G0401</emdnCode>
    <emdnDescription>ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>11299634</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-22T12:20:01.123Z</lastUpdated>
  </row>
  <row>
    <udiDi>111129964077</udiDi>
    <basicUdiDi>PP23833V9017.IIB.A68</basicUdiDi>
    <tradeName>Fructaid</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Vitacare GmbH &amp; Co. KG</manufacturerName>
    <manufacturerSrn>DE-MF-000022472</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>G0401</emdnCode>
    <emdnDescription>ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>11299640</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-22T12:20:01.099Z</lastUpdated>
  </row>
  <row>
    <udiDi>111750233288</udiDi>
    <basicUdiDi>PP23833V9017.IIB.A68</basicUdiDi>
    <tradeName>Fructaid</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Vitacare GmbH &amp; Co. KG</manufacturerName>
    <manufacturerSrn>DE-MF-000022472</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>G0401</emdnCode>
    <emdnDescription>ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>17502332</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-22T12:19:47.333Z</lastUpdated>
  </row>
  <row>
    <udiDi>111750234978</udiDi>
    <basicUdiDi>PP23833V9017.IIB.A68</basicUdiDi>
    <tradeName>Fructaid</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Vitacare GmbH &amp; Co. KG</manufacturerName>
    <manufacturerSrn>DE-MF-000022472</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>G0401</emdnCode>
    <emdnDescription>ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>17502349</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-22T12:19:47.315Z</lastUpdated>
  </row>
  <row>
    <udiDi>111750235544</udiDi>
    <basicUdiDi>PP23833V9017.IIB.A68</basicUdiDi>
    <tradeName>Fructaid</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Vitacare GmbH &amp; Co. KG</manufacturerName>
    <manufacturerSrn>DE-MF-000022472</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>G0401</emdnCode>
    <emdnDescription>ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>17502355</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-22T12:19:47.293Z</lastUpdated>
  </row>
  <row>
    <udiDi>112065739204</udiDi>
    <basicUdiDi>PP07498KPRO16</basicUdiDi>
    <tradeName>KIJIMEA® REIZDARM PRO</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Synformulas GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000016381</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>G0401</emdnCode>
    <emdnDescription>ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>N/A</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-22T12:19:08.183Z</lastUpdated>
  </row>
  <row>
    <udiDi>112065740095</udiDi>
    <basicUdiDi>PP07498KPRO16</basicUdiDi>
    <tradeName>KIJIMEA® REIZDARM PRO</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Synformulas GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000016381</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>G0401</emdnCode>
    <emdnDescription>ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>N/A</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-22T12:19:08.163Z</lastUpdated>
  </row>
  <row>
    <udiDi>112065741785</udiDi>
    <basicUdiDi>PP07498KPRO16</basicUdiDi>
    <tradeName>KIJIMEA® COLON IRRITABILE PRO</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Synformulas GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000016381</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>G0401</emdnCode>
    <emdnDescription>ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>N/A</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-22T12:19:08.133Z</lastUpdated>
  </row>
  <row>
    <udiDi>112065742351</udiDi>
    <basicUdiDi>PP07498KPRO16</basicUdiDi>
    <tradeName>KIJIMEA® COLON IRRITABILE PRO</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Synformulas GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000016381</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>G0401</emdnCode>
    <emdnDescription>ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>N/A</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-22T12:19:08.104Z</lastUpdated>
  </row>
  <row>
    <udiDi>112065744607</udiDi>
    <basicUdiDi>PP07498KPRO16</basicUdiDi>
    <tradeName>KIJIMEA® COLON IRRITABILE PRO</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Synformulas GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000016381</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>G0401</emdnCode>
    <emdnDescription>ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>N/A</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-22T12:19:08.070Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-ITMF0000247100074A8</udiDi>
    <basicUdiDi>B-ITMF0000247100074A8</basicUdiDi>
    <tradeName>Aroè</tradeName>
    <deviceName>ANTIREFLUSSO</deviceName>
    <manufacturerName>Biofarma S.r.l.</manufacturerName>
    <manufacturerSrn>IT-MF-000024710</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>G0401</emdnCode>
    <emdnDescription>ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>NA</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-07-22T00:30:48.729Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-ITMF00002471000309L</udiDi>
    <basicUdiDi>B-ITMF00002471000309L</basicUdiDi>
    <tradeName>REFLU-G</tradeName>
    <deviceName>ANTIREFLUSSO</deviceName>
    <manufacturerName>Biofarma S.r.l.</manufacturerName>
    <manufacturerSrn>IT-MF-000024710</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>G0401</emdnCode>
    <emdnDescription>ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>NA</reference>
    <placedOnMarketCountry>Poland</placedOnMarketCountry>
    <lastUpdated>2026-07-22T00:30:47.142Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-ITMF0000247100029A3</udiDi>
    <basicUdiDi>B-ITMF0000247100029A3</basicUdiDi>
    <tradeName>Aroè</tradeName>
    <deviceName>ANTIREFLUSSO</deviceName>
    <manufacturerName>Biofarma S.r.l.</manufacturerName>
    <manufacturerSrn>IT-MF-000024710</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>G0401</emdnCode>
    <emdnDescription>ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>NA</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-07-22T00:30:46.345Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-ITMF00002471000199Y</udiDi>
    <basicUdiDi>B-ITMF00002471000199Y</basicUdiDi>
    <tradeName>AQUILEA VERDAUUNG TOTAL</tradeName>
    <deviceName>ACID STOP</deviceName>
    <manufacturerName>Biofarma S.r.l.</manufacturerName>
    <manufacturerSrn>IT-MF-000024710</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>G0401</emdnCode>
    <emdnDescription>ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>NA</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-07-22T00:30:44.748Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-ITM29499PBLVADIAOPPT5</udiDi>
    <basicUdiDi>B-ITM29499PBLVADIAOPPT5</basicUdiDi>
    <tradeName>Lenodiar Adult</tradeName>
    <deviceName>Antidiarroico adulti</deviceName>
    <manufacturerName>ABOCA S.P.A. SOCIETÀ AGRICOLA</manufacturerName>
    <manufacturerSrn>IT-MF-000029499</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>G0401</emdnCode>
    <emdnDescription>ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>PBLVADIAOPP</reference>
    <placedOnMarketCountry>Lithuania</placedOnMarketCountry>
    <lastUpdated>2026-07-22T00:30:42.316Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-ITM29499PBADIAOPXFF</udiDi>
    <basicUdiDi>B-ITM29499PBADIAOPXFF</basicUdiDi>
    <tradeName>Lenodiar Adult</tradeName>
    <deviceName>Antidiarroico adulti</deviceName>
    <manufacturerName>ABOCA S.P.A. SOCIETÀ AGRICOLA</manufacturerName>
    <manufacturerSrn>IT-MF-000029499</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>G0401</emdnCode>
    <emdnDescription>ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>PBADIAOPX</reference>
    <placedOnMarketCountry>Lithuania</placedOnMarketCountry>
    <lastUpdated>2026-07-22T00:30:40.735Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-ITM29499ESGASDISRPNY</udiDi>
    <basicUdiDi>B-ITM29499ESGASDISRPNY</basicUdiDi>
    <tradeName>GastroDiger</tradeName>
    <deviceName>Dispepsia Fluido</deviceName>
    <manufacturerName>ABOCA S.P.A. SOCIETÀ AGRICOLA</manufacturerName>
    <manufacturerSrn>IT-MF-000029499</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>G0401</emdnCode>
    <emdnDescription>ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>ESGASDISRP/ESGASDIIMSRP</reference>
    <placedOnMarketCountry>Spain</placedOnMarketCountry>
    <lastUpdated>2026-07-22T00:30:38.316Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-ITM29499DEADIAOPX8L</udiDi>
    <basicUdiDi>B-ITM29499DEADIAOPX8L</basicUdiDi>
    <tradeName>Lenodiar Erwachsene</tradeName>
    <deviceName>Antidiarroico adulti</deviceName>
    <manufacturerName>ABOCA S.P.A. SOCIETÀ AGRICOLA</manufacturerName>
    <manufacturerSrn>IT-MF-000029499</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>G0401</emdnCode>
    <emdnDescription>ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>DEADIAOPX/ATADIAOPX</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-07-22T00:30:35.919Z</lastUpdated>
  </row>
</eudamedExport>